vs

Side-by-side financial comparison of CAL-MAINE FOODS INC (CALM) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $769.5M, roughly 1.4× CAL-MAINE FOODS INC). CAL-MAINE FOODS INC runs the higher net margin — 13.4% vs -127.8%, a 141.2% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -19.4%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $47.9M). Over the past eight quarters, CAL-MAINE FOODS INC's revenue compounded faster (29.4% CAGR vs 1.3%).

Cal-Maine Foods, Inc. is an American fresh egg producer based in Ridgeland, Mississippi. As of 2024, it was the largest egg producer in the United States. Its eggs are sold under several different brand names, including Egg-Land's Best, Land O'Lakes, Farmhouse Eggs, Sunups, Sunny Meadow, and 4-Grain. The company was founded in 1957 by Fred R. Adams, Jr., whose family owns a controlling interest in the company, which is publicly traded on the NASDAQ stock exchange.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

CALM vs PRGO — Head-to-Head

Bigger by revenue
PRGO
PRGO
1.4× larger
PRGO
$1.1B
$769.5M
CALM
Growing faster (revenue YoY)
PRGO
PRGO
+16.9% gap
PRGO
-2.5%
-19.4%
CALM
Higher net margin
CALM
CALM
141.2% more per $
CALM
13.4%
-127.8%
PRGO
More free cash flow
PRGO
PRGO
$100.7M more FCF
PRGO
$148.6M
$47.9M
CALM
Faster 2-yr revenue CAGR
CALM
CALM
Annualised
CALM
29.4%
1.3%
PRGO

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CALM
CALM
PRGO
PRGO
Revenue
$769.5M
$1.1B
Net Profit
$102.8M
$-1.4B
Gross Margin
27.0%
32.6%
Operating Margin
16.1%
-116.0%
Net Margin
13.4%
-127.8%
Revenue YoY
-19.4%
-2.5%
Net Profit YoY
-53.1%
-3093.9%
EPS (diluted)
$2.13
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CALM
CALM
PRGO
PRGO
Q4 25
$769.5M
$1.1B
Q3 25
$922.6M
$1.0B
Q2 25
$1.1B
Q1 25
$1.4B
$1.0B
Q4 24
$954.7M
$1.1B
Q3 24
$785.9M
$1.1B
Q2 24
$1.1B
Q1 24
$703.1M
$1.1B
Net Profit
CALM
CALM
PRGO
PRGO
Q4 25
$102.8M
$-1.4B
Q3 25
$199.3M
$7.5M
Q2 25
$-8.4M
Q1 25
$508.5M
$-6.4M
Q4 24
$219.1M
$-44.4M
Q3 24
$150.0M
$-21.0M
Q2 24
$-108.4M
Q1 24
$146.7M
$2.0M
Gross Margin
CALM
CALM
PRGO
PRGO
Q4 25
27.0%
32.6%
Q3 25
33.7%
36.1%
Q2 25
34.4%
Q1 25
50.5%
37.6%
Q4 24
37.3%
33.9%
Q3 24
31.5%
37.2%
Q2 24
37.0%
Q1 24
31.1%
33.1%
Operating Margin
CALM
CALM
PRGO
PRGO
Q4 25
16.1%
-116.0%
Q3 25
27.0%
7.0%
Q2 25
4.3%
Q1 25
44.8%
4.5%
Q4 24
29.1%
10.0%
Q3 24
23.8%
7.4%
Q2 24
-2.5%
Q1 24
23.2%
-5.1%
Net Margin
CALM
CALM
PRGO
PRGO
Q4 25
13.4%
-127.8%
Q3 25
21.6%
0.7%
Q2 25
-0.8%
Q1 25
35.9%
-0.6%
Q4 24
22.9%
-3.9%
Q3 24
19.1%
-1.9%
Q2 24
-10.2%
Q1 24
20.9%
0.2%
EPS (diluted)
CALM
CALM
PRGO
PRGO
Q4 25
$2.13
$-10.23
Q3 25
$4.12
$0.05
Q2 25
$-0.06
Q1 25
$10.38
$-0.05
Q4 24
$4.47
$-0.32
Q3 24
$3.06
$-0.15
Q2 24
$-0.79
Q1 24
$3.00
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CALM
CALM
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$369.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$2.9B
Total Assets
$3.1B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CALM
CALM
PRGO
PRGO
Q4 25
$369.4M
Q3 25
$251.9M
$432.1M
Q2 25
$454.2M
Q1 25
$497.2M
$409.9M
Q4 24
$140.3M
$558.8M
Q3 24
$181.7M
$1.5B
Q2 24
$542.8M
Q1 24
$367.1M
$658.5M
Stockholders' Equity
CALM
CALM
PRGO
PRGO
Q4 25
$2.7B
$2.9B
Q3 25
$2.7B
$4.4B
Q2 25
$4.5B
Q1 25
$2.4B
$4.4B
Q4 24
$2.0B
$4.3B
Q3 24
$1.9B
$4.6B
Q2 24
$4.5B
Q1 24
$1.7B
$4.7B
Total Assets
CALM
CALM
PRGO
PRGO
Q4 25
$3.1B
$8.5B
Q3 25
$3.2B
$10.1B
Q2 25
$10.1B
Q1 25
$3.1B
$9.8B
Q4 24
$2.5B
$9.6B
Q3 24
$2.4B
$11.2B
Q2 24
$10.4B
Q1 24
$2.1B
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CALM
CALM
PRGO
PRGO
Operating Cash FlowLast quarter
$94.8M
$175.4M
Free Cash FlowOCF − Capex
$47.9M
$148.6M
FCF MarginFCF / Revenue
6.2%
13.4%
Capex IntensityCapex / Revenue
6.1%
2.4%
Cash ConversionOCF / Net Profit
0.92×
TTM Free Cash FlowTrailing 4 quarters
$895.9M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CALM
CALM
PRGO
PRGO
Q4 25
$94.8M
$175.4M
Q3 25
$278.6M
$51.7M
Q2 25
$75.9M
Q1 25
$571.6M
$-64.5M
Q4 24
$122.7M
$312.6M
Q3 24
$117.5M
$42.2M
Q2 24
$9.5M
Q1 24
$164.0M
$-1.4M
Free Cash Flow
CALM
CALM
PRGO
PRGO
Q4 25
$47.9M
$148.6M
Q3 25
$233.3M
$29.8M
Q2 25
$56.7M
Q1 25
$521.8M
$-90.0M
Q4 24
$92.9M
$274.9M
Q3 24
$81.7M
$15.1M
Q2 24
$-18.9M
Q1 24
$133.8M
$-26.5M
FCF Margin
CALM
CALM
PRGO
PRGO
Q4 25
6.2%
13.4%
Q3 25
25.3%
2.9%
Q2 25
5.4%
Q1 25
36.8%
-8.6%
Q4 24
9.7%
24.2%
Q3 24
10.4%
1.4%
Q2 24
-1.8%
Q1 24
19.0%
-2.4%
Capex Intensity
CALM
CALM
PRGO
PRGO
Q4 25
6.1%
2.4%
Q3 25
4.9%
2.1%
Q2 25
1.8%
Q1 25
3.5%
2.4%
Q4 24
3.1%
3.3%
Q3 24
4.6%
2.5%
Q2 24
2.7%
Q1 24
4.3%
2.3%
Cash Conversion
CALM
CALM
PRGO
PRGO
Q4 25
0.92×
Q3 25
1.40×
6.89×
Q2 25
Q1 25
1.12×
Q4 24
0.56×
Q3 24
0.78×
Q2 24
Q1 24
1.12×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CALM
CALM

Retail$625.4M81%
Prepared Foods$71.7M9%
Egg Products$34.5M4%
Service Other$19.2M2%
Other$13.8M2%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons